FORTIGEL® for Joint Health

Osteoarthritis – degeneration of the joints – is the most commonly occurring joint disease worldwide. In spite of the considerable progress made in medical research in recent years, the disease cannot be healed; not only that, the therapeutic possibilities available for the treatment of degenerative joint disease are extremely limited. FORTIGEL® is a new and promising therapeutic agent for the disease. Collagen Peptides (CP) specifically stimulate cartilage metabolism and enhance the synthesis of cartilage cells. In this way progressive loss of cartilage tissue can be counteracted.

Current treatment options for osteoarthritis include pain relief with analgesics, anti-inflammatory drugs and preserving joint function by exercise, and finally joint arthroplasty.

Besides the traditional treatments, some nutritional supplements such as glucosamine and chondroitin have been investigated for the treatment of patients with osteoarthritis and joint pain. Despite the widespread use of

these agents, there are still concerns about their efficacy. Moreover, some products have been linked to various safety issues, including their use in diabetic patients, allergic reactions, and lack of standardization in preparations.

The ultimate goal of osteoarthritis treatment is not only to relieve symptoms but also to slow or even halt disease progression and thus improving the quality of life of people affected.

<  1  2  3  >